Troubled pharmaceutical maker Amgen said Tuesday it received a subpoena from the New York attorney general seeking documents related to its promotional and other activities.
The subpoena also sought documents on the company's sales and marketing activities, medical education, clinical studies, pricing and contracting, license and distribution agreements and corporate communications.
Amgen received the subpoena May 10, according to a Securities and Exchange Commission filing. "Amgen intends to fully cooperate in responding to the subpoena," the company said in the filing.
More at Forbes
No comments:
Post a Comment